First-in-Class Drug Wins FDA Approval for Polycythemia Vera
01/09/2026
Aprobación de nuevo fármaco La FDA ha aprobado el primer fármaco de su clase, rusfertide (Mimrylo), para el tratamiento de
Aprobación de nuevo fármaco La FDA ha aprobado el primer fármaco de su clase, rusfertide (Mimrylo), para el tratamiento de
Clinical takeaway: Hip fracture risk may soon be predictable before the first fracture, without adding clinic workload. Identifying who will
Nota sobre enlaces Note that some links may require registration or subscription. Preocupaciones sobre el peso de Trump Doctors shared
New Leadership at NIH The NIH has appointed Dr. John Gaitanis, a pediatric neurologist known for his controversial views on
In the wake of a controversial executive orderopens in a new tab or window that shrinks the number of universally